1. Home
  2. GROV vs NTRB Comparison

GROV vs NTRB Comparison

Compare GROV & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.53

Market Cap

62.9M

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.04

Market Cap

57.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
NTRB
Founded
2016
2016
Country
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.9M
57.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GROV
NTRB
Price
$1.53
$4.04
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$1.60
N/A
AVG Volume (30 Days)
62.5K
11.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.17
Revenue Next Year
$3.63
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$3.96
52 Week High
$1.72
$11.68

Technical Indicators

Market Signals
Indicator
GROV
NTRB
Relative Strength Index (RSI) 64.30 39.27
Support Level $1.44 $3.96
Resistance Level $1.55 $4.35
Average True Range (ATR) 0.06 0.24
MACD -0.00 -0.03
Stochastic Oscillator 86.66 8.43

Price Performance

Historical Comparison
GROV
NTRB

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: